| Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity JI Mayordomo, T Zorina, WJ Storkus, L Zitvogel, C Celluzzi, LD Falo, ... Nature medicine 1 (12), 1297-1302, 1995 | 1375 | 1995 |
| Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. L Zitvogel, JI Mayordomo, T Tjandrawan, AB DeLeo, MR Clarke, MT Lotze, ... The Journal of experimental medicine 183 (1), 87-97, 1996 | 1145 | 1996 |
| Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. CM Celluzzi, JI Mayordomo, WJ Storkus, MT Lotze, LD Falo Jr The Journal of experimental medicine 183 (1), 283-287, 1996 | 1035 | 1996 |
| Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. CL Nastala, HD Edington, TG McKinney, H Tahara, MA Nalesnik, ... Journal of immunology (Baltimore, Md.: 1950) 153 (4), 1697-1706, 1994 | 978 | 1994 |
| α-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity RB Mailliard, A Wankowicz-Kalinska, Q Cai, A Wesa, CM Hilkens, ... Cancer research 64 (17), 5934-5937, 2004 | 626 | 2004 |
| Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes EU Wieckowski, C Visus, M Szajnik, MJ Szczepanski, WJ Storkus, ... The Journal of Immunology 183 (6), 3720-3730, 2009 | 616 | 2009 |
| NK susceptibility varies inversely with target cell class I HLA antigen expression. WJ Storkus, DN Howell, RD Salter, JR Dawson, P Cresswell Journal of immunology (Baltimore, Md.: 1950) 138 (6), 1657-1659, 1987 | 538 | 1987 |
| Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function RB Mailliard, YI Son, R Redlinger, PT Coates, A Giermasz, PA Morel, ... The Journal of Immunology 171 (5), 2366-2373, 2003 | 450 | 2003 |
| Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB10401+ Patients With Renal Cell Carcinoma or … T Tatsumi, LS Kierstead, E Ranieri, L Gesualdo, FP Schena, JH Finke, ... The Journal of experimental medicine 196 (5), 619-628, 2002 | 402 | 2002 |
| Fibroblasts Genetically Engineered to Secrete Interleukin 12 Can Suppress Tumor Growth and Induce Antitumor Immunity to a Murine Melanoma in Vivo H Tahara, HJ Zeh III, WJ Storkus, I Pappo, SC Watkins, U Gubler, SF Wolf, ... Cancer research 54 (1), 182-189, 1994 | 394 | 1994 |
| Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of … MJ Maeurer, SM Gollin, D Martin, W Swaney, J Bryant, C Castelli, ... The Journal of clinical investigation 98 (7), 1633-1641, 1996 | 384 | 1996 |
| Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy U Keilholz, J Weber, JH Finke, DI Gabrilovich, WM Kast, ML Disis, ... Journal of immunotherapy 25 (2), 97-138, 2002 | 382 | 2002 |
| Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. WJ Storkus, J Alexander, JA Payne, JR Dawson, P Cresswell Proceedings of the National Academy of Sciences 86 (7), 2361-2364, 1989 | 340 | 1989 |
| Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. H Tahara, L Zitvogel, WJ Storkus, HJ Zeh 3rd, TG McKinney, ... Journal of immunology (Baltimore, Md.: 1950) 154 (12), 6466-6474, 1995 | 325 | 1995 |
| Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines. JI Mayordomo, DJ Loftus, H Sakamoto, CM De Cesare, PM Appasamy, ... The Journal of experimental medicine 183 (4), 1357-1365, 1996 | 314 | 1996 |
| Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution WJ Storkus, HJ Zen III, RD Salter, MT Lotze Journal of immunotherapy 14 (2), 94-103, 1993 | 304 | 1993 |
| Immunopolarization of CD4+ and CD8+ T cells to type-1–like is associated with melanocyte loss in human vitiligo A Wańkowicz-Kalińska, RM van den Wijngaard, BJ Tigges, W Westerhof, ... Laboratory investigation 83 (5), 683-695, 2003 | 275 | 2003 |
| Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by … T Tuting, CC Wilson, DM Martin, YL Kasamon, J Rowles, DI Ma, ... The Journal of Immunology 160 (3), 1139-1147, 1998 | 270 | 1998 |
| Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes. C Castelli, WJ Storkus, MJ Maeurer, DM Martin, EC Huang, BN Pramanik, ... The Journal of experimental medicine 181 (1), 363-368, 1995 | 259 | 1995 |
| Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. L Zitvogel, H Tahara, PD Robbins, WJ Storkus, MR Clarke, MA Nalesnik, ... Journal of immunology (Baltimore, Md.: 1950) 155 (3), 1393-1403, 1995 | 255 | 1995 |
